149 related articles for article (PubMed ID: 17193188)
1. Inhibition of glycosylation processes: the reaction between pyridoxamine and glucose.
Adrover M; Vilanova B; Muñoz F; Donoso J
Chem Biodivers; 2005 Jul; 2(7):964-75. PubMed ID: 17193188
[TBL] [Abstract][Full Text] [Related]
2. The pyridoxamine action on Amadori compounds: A reexamination of its scavenging capacity and chelating effect.
Adrover M; Vilanova B; Frau J; Muñoz F; Donoso J
Bioorg Med Chem; 2008 May; 16(10):5557-69. PubMed ID: 18434162
[TBL] [Abstract][Full Text] [Related]
3. Amadorins: novel post-Amadori inhibitors of advanced glycation reactions.
Khalifah RG; Baynes JW; Hudson BG
Biochem Biophys Res Commun; 1999 Apr; 257(2):251-8. PubMed ID: 10198198
[TBL] [Abstract][Full Text] [Related]
4. A comparative study of the chemical reactivity of pyridoxamine, Ac-Phe-Lys and Ac-Cys with various glycating carbonyl compounds.
Adrover M; Vilanova B; Frau J; Muñoz F; Donoso J
Amino Acids; 2009 Mar; 36(3):437-48. PubMed ID: 18480960
[TBL] [Abstract][Full Text] [Related]
5. Reaction of pyridoxamine with malondialdehyde: mechanism of inhibition of formation of advanced lipoxidation end-products.
Kang Z; Li H; Li G; Yin D
Amino Acids; 2006 Feb; 30(1):55-61. PubMed ID: 15990947
[TBL] [Abstract][Full Text] [Related]
6. Thiamine pyrophosphate and pyridoxamine inhibit the formation of antigenic advanced glycation end-products: comparison with aminoguanidine.
Booth AA; Khalifah RG; Hudson BG
Biochem Biophys Res Commun; 1996 Mar; 220(1):113-9. PubMed ID: 8602828
[TBL] [Abstract][Full Text] [Related]
7. Effect of pyridoxamine on acrylamide formation in a glucose/asparagine model system.
Arribas-Lorenzo G; Morales FJ
J Agric Food Chem; 2009 Feb; 57(3):901-9. PubMed ID: 19143489
[TBL] [Abstract][Full Text] [Related]
8. High- and low-spin Fe(III) complexes of various AGE inhibitors.
Ortega-Castro J; Frau J; Casasnovas R; Fernández D; Donoso J; Muñoz F
J Phys Chem A; 2012 Mar; 116(11):2961-71. PubMed ID: 22369344
[TBL] [Abstract][Full Text] [Related]
9. Unexpected isomeric equilibrium in pyridoxamine Schiff bases.
Adrover M; Vilanova B; Muñoz F; Donoso J
Bioorg Chem; 2009 Feb; 37(1):26-32. PubMed ID: 19091373
[TBL] [Abstract][Full Text] [Related]
10. Effect of pyridoxamine (K-163), an inhibitor of advanced glycation end products, on type 2 diabetic nephropathy in KK-A(y)/Ta mice.
Tanimoto M; Gohda T; Kaneko S; Hagiwara S; Murakoshi M; Aoki T; Yamada K; Ito T; Matsumoto M; Horikoshi S; Tomino Y
Metabolism; 2007 Feb; 56(2):160-7. PubMed ID: 17224327
[TBL] [Abstract][Full Text] [Related]
11. Propagation of protein glycation damage involves modification of tryptophan residues via reactive oxygen species: inhibition by pyridoxamine.
Chetyrkin SV; Mathis ME; Ham AJ; Hachey DL; Hudson BG; Voziyan PA
Free Radic Biol Med; 2008 Apr; 44(7):1276-85. PubMed ID: 18374270
[TBL] [Abstract][Full Text] [Related]
12. The structure of the sugar residue in glycated human serum albumin and its molecular recognition by phenylboronate.
Rohovec J; Maschmeyer T; Aime S; Peters JA
Chemistry; 2003 May; 9(10):2193-9. PubMed ID: 12772293
[TBL] [Abstract][Full Text] [Related]
13. A quantitative model of the generation of N(epsilon)-(carboxymethyl)lysine in the Maillard reaction between collagen and glucose.
Ferreira AE; Ponces Freire AM; Voit EO
Biochem J; 2003 Nov; 376(Pt 1):109-21. PubMed ID: 12911334
[TBL] [Abstract][Full Text] [Related]
14. Aged garlic extract and S-allyl cysteine prevent formation of advanced glycation endproducts.
Ahmad MS; Pischetsrieder M; Ahmed N
Eur J Pharmacol; 2007 Apr; 561(1-3):32-8. PubMed ID: 17321518
[TBL] [Abstract][Full Text] [Related]
15. Effects of pyridoxamine (K-163) on glucose intolerance and obesity in high-fat diet C57BL/6J mice.
Hagiwara S; Gohda T; Tanimoto M; Ito T; Murakoshi M; Ohara I; Yamazaki T; Matsumoto M; Horikoshi S; Funabiki K; Tomino Y
Metabolism; 2009 Jul; 58(7):934-45. PubMed ID: 19427656
[TBL] [Abstract][Full Text] [Related]
16. Vitamin B6 group; urinary excretion of pyridoxal, pyridoxamine, pyridoxine, and 4-pyridoxic acid in human subjects.
RABINWITZ JC; SNELL EE
Proc Soc Exp Biol Med; 1949 Feb; 70(2):235-40. PubMed ID: 18124327
[No Abstract] [Full Text] [Related]
17. Post-Amadori AGE inhibition as a therapeutic target for diabetic complications: a rational approach to second-generation Amadorin design.
Khalifah RG; Chen Y; Wassenberg JJ
Ann N Y Acad Sci; 2005 Jun; 1043():793-806. PubMed ID: 16037307
[TBL] [Abstract][Full Text] [Related]
18. DFT studies on Schiff base formation of vitamin B6 analogues. Reaction between a pyridoxamine-analogue and carbonyl compounds.
Ortega-Castro J; Adrover M; Frau J; Salvà A; Donoso J; Muñoz F
J Phys Chem A; 2010 Apr; 114(13):4634-40. PubMed ID: 20235562
[TBL] [Abstract][Full Text] [Related]
19. In vitro glycation of brain aminophospholipids by acetoacetate and its inhibition by urea.
Aguilar-Hernández M; Méndez JD
Biomed Pharmacother; 2007 Dec; 61(10):693-7. PubMed ID: 17640846
[TBL] [Abstract][Full Text] [Related]
20. Pyridoxamine: the many virtues of a maillard reaction inhibitor.
Voziyan PA; Hudson BG
Ann N Y Acad Sci; 2005 Jun; 1043():807-16. PubMed ID: 16037308
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
